Bizarre Patents
Reward Candy Dispenser for Personal Computers
A personal computer peripheral, battery powered reward candy dispenser which immediately presents students with a single candy for each problem completed correctly.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120129870 | PIPERAZINYL DERIVATIVES USEFUL AS MODULATORS OF THE NEUROPEPTIDE Y2 RECEPTOR The present invention is directed to piperidinyl and piperazinyl derivatives of formula (II) useful as inhibitors of the NPY Y2 receptor, pharmaceutical compositions comprising said compounds, processes for the preparation of said compounds and the use of said compounds... | 05/24/2012 |
| 20120129811 | TRICYCLIC INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION This invention relates to tricycle I and its therapeutic and prophylactic uses, wherein the variables C1, C2, Z1, Z2, Q, J, R1, and R3 are defined in the specification. Disorders treated and/or prevented ... | 05/24/2012 |
| 20120108815 | BIFUNCTIONAL/POLYFUNCTIONAL DOPAMINE D2/D3 AGONIST AS NEUROPROTECTIVE AGENTS FOR TREATMENT OF NEURODEGENERATIVE DISEASES A precursor for the deposition of a thin film by atomic layer deposition is provided. The compound has the formula MxLy where M is a metal and L is an amidrazone-derived ligand or an amidate-derived ligand. A process of forming a thin film using th... | 05/03/2012 |
| 20120022254 | SIRTUIN MODULATING COMPOUNDS Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, disease... | 01/26/2012 |
| 20120015959 | HETEROCYCLIC COMPOUNDS AS AUTOTAXIN INHIBITORS Compounds of the formula (I), in which Het, R, X, Y, R1 and p have the meanings indicated in claim 1, are autotaxin inhibitors and can be employed for the treatment of tumours.... | 01/19/2012 |
| 20120016124 | SEROTONIN REUPTAKE INHIBITORS A serotonin reuptake inhibitor which can be used in the treatment of depression and which has a decreased occurrence of unwanted side effects. The serotonin reuptake inhibitors are bi-functional organic molecules which combine serotonin transporter reuptake inhibition w... | 01/19/2012 |
| 20120015954 | THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN A compound of formula: wherein Ar1, A, R3, x, and m are as disclosed herein and Ar2 is a benzothiazolyl, benzooxazolyl, or benzoimidazolyl group or a pharmaceutically acceptab... | 01/19/2012 |
| 20120004213 | NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE The present invention relates to piperazine derivatives that act as inhibitors of stearoyl-CoA desaturase. The invention also relates to methods of preparing the compounds, compositions containing the compounds, and to methods of treatment using the compounds.... | 01/05/2012 |
| 20110319423 | NOVEL DOPAMINE D3 RECEPTOR LIGANDS AND PREPARATION AND MEDICAL USES OF THE SAME The present invention relates to a novel piperazine derivative represented by Formula I having an activity for regulating dopamine D3 receptor, stereoisomers thereof, pharmaceutically acceptable salts or solvates, and a pharmaceutical composition comprising the compound... | 12/29/2011 |
| 20110301176 | IMIDAZOTHIAZOLE DERIVATIVES HAVING PROLINE RING STRUCTURE There is provided compounds that inhibit interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity. Compounds include imidazothiazole derivatives that can inhibit interaction between Mdm2 protein and p53 protein and exhib... | 12/08/2011 |
| 20110301133 | COMPOSITIONS OF PROTEIN RECEPTOR TYROSINE KINASE INHIBITORS The present invention relates to novel synthetic substituted heterocyclic compounds and pharmaceutical compositions containing the same that are capable of inhibiting or antagonizing a family of receptor tyrosine kinases, Tropomysosin Related Kinases (Trk), in particula... | 12/08/2011 |
| 20110294822 | Substituted Phenylpiperazinyl Aralkylalcohol Derivatives, Pharmaceutical Compositions Containing Such Derivatives and Uses Thereof The invention relates to a substituted phenylpiperazine aryl alkanol derivative represented by the following general formula and its salt and hydrate, wherein C1 and C2 represent chiral ... | 12/01/2011 |
| 20110280804 | HIGHLY SELECTIVE SIGMA RECEPTOR RADIOLIGANDS Compounds having the general formula III′, or IV′ wherein R1 can be a radical of an optionally substituted C-4 to C-7 N-containing heterocycle or a radical of an optionally substituted cyclic o... | 11/17/2011 |
| 20110269756 | BENZOTHIAZOLONE DERIVATIVES Compounds of the formula I, in which R1, R2, R3, R3′, R4, R4′, E, E′, E″ and E′″ have the meanings indicated in Claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, an... | 11/03/2011 |
| 20110263848 | PROCESS OF A QUATERNARY AMMONIUM SALT USING PHOSPHATE The present invention relates to a novel process for preparing quaternary ammonium salt derivatives.... | 10/27/2011 |
| 20110263562 | BICYCLIC COMPOUND The present invention provides to a compound having an ACC inhibitory action, which is useful as an agent for the prophylaxis or treatment of obesity, diabetes, hypertension, hyperlipidemia, cardiac failure, diabetic complications, metabolic syndrome, sarcopenia, cancer... | 10/27/2011 |
| 20110263847 | PROCESS OF A QUATERNARY AMMONIUM SALT The present invention relates to a novel process for preparing quaternary ammonium salt derivatives.... | 10/27/2011 |
| 20110257077 | COMPOUNDS AND COMPOSITIONS AS CHANNEL ACTIVATING PROTEASE INHIBITORS The invention provides compounds and pharmaceutical compositions thereof, which are useful for modulating channel activating proteases, and methods for, using such compounds to treat, ameliorate or prevent a condition associated with a channel activating protease, inclu... | 10/20/2011 |
| 20110251212 | PIPERAZINE DERIVATIVES A compound which specifically binds to a receptor of NR1/NR2B, and is used as a NR2B receptor antagonist is provided. It has been found out that a piperazine derivative represented by the formula (I) binds specifically to a receptor of NR1/... | 10/13/2011 |
| 20110251214 | MONOHYDRATE OF PARDOPRUNOX This invention relates to a process for the preparation of 7-(4-methyl-1-piperazinyl)benzoxazol-2(3H)-one hydrochloride, a partial dopamine-D2 receptor agonist and a full serotonin 5-HT1A receptor agonist. | 10/13/2011 |
| 20110207933 | PROCESS FOR THE PREPARATION OF ZIPRASIDONE The invention relates to processes for the preparation of substantially pure ziprasidone. The invention also relates to the preparation of acid addition salts of ziprasidone. More particularly, it relates to the preparation of substantially pure hydrochloride salt of zi... | 08/25/2011 |
| 20110195955 | HIGHLY SELECTIVE SIGMA RECEPTOR LIGANDS A compound useful for treating subjects in need of therapy involving sigma receptors or for alleviation of affects resulting from drug abuse having the general formula I in which R1 can be a radica... | 08/11/2011 |
| 20110182828 | C20-C21 SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS The present invention provides compounds of Formula (I), and pharmaceutically acceptable salts, solvates, esters, prodrugs, tautomers, or isomers of said compounds), having the general structure: wherein L, R... | 07/28/2011 |
| 20110183993 | CYCLOALKANE DERIVATIVE The present invention relates to a novel cycloalkane derivative which has an excellent psychotropic action.... | 07/28/2011 |
| 20110178091 | ARYLPIPERAZINE-CONTAINING PYRROLE 3-CARBOXAMIDE DERIVATIVES FOR TREATING DEPRESSIVE DISORDERS The present invention relates to novel arylpiperazine-containing pyrrole 3-carboxamide derivatives of formula (I) or a pharmaceutically acceptable salt thereof which is useful for preventing or treating depressive disorders. The present invention also provides a method ... | 07/21/2011 |
| 20110172245 | HETEROCYCLIC COMPOUND AND USE THEREOF Provided is a heterocyclic compound showing strong Raf inhibitory activity. A compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.... | 07/14/2011 |
| 20110172415 | NITROGEN-CONTAINING HETEROCYCLE DERIVATIVES SUBSTITUTED WITH CYCLIC GROUP It was found out that the nitrogen-containing heterocyclic derivative represented by the formula (I) specifically binds to a receptor of NR1/NR2B, and is used as a NR2B receptor antagonist. A compound represented by: | 07/14/2011 |
| 20110166156 | Prodrugs for the Treatment of Schizophrenia and Bipolar Disease Compounds of Formula I and Formula II and their use for the treatment of neurological and psychiatric disorders including schizophrenia and manic or mixed episodes associated with bipolar I disorder with or without psychotic features is disclosed. | 07/07/2011 |
| 20110160199 | Aralkyl Substituted Piperidine or Piperazine Derivatives and Their Use for Treating Schizophrenia The present invention discloses an aralkyl substituted piperidine or piperazine derivative and the use of the derivative in preparation of medicaments for treating schizophrenia and correlative psychoneuroses. It is shown by pharmacological tests that the derivative of ... | 06/30/2011 |
| 20110152251 | COMPOUNDS FOR MODULATING TLR2 The present invention is directed to methods, kits, and uses of inhibitors of LCMV mediated NF-κB activation to treat viral infections and inflammatory conditions.... | 06/23/2011 |
| 20110152287 | SUBSTITUTED BENZOTHIAZOLE AND BENZOXAZOLE DERIVATIVES USEFUL AS INHIBITORS OF DPP-1 The present invention is directed to substituted benzothiazole and benzoxazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by DPP-1.... | 06/23/2011 |
| 20110124659 | CYCLOALKANE DERIVATIVE The present invention relates to a novel cycloalkane derivative which has a useful psychotropic action with less side effect.... | 05/26/2011 |
| 20110105523 | BIFEPRUNOX DERIVATIVES The present invention relates to bifeprunox derivatives of formula (I) wherein R1 is one substituent chosen from 3-OH, 4-OH, 3-OSO3H and 4-OSO3H; R2 is H; or an N-oxide or a pharmaceutically acceptable salt, or a solvate or hydrate of any of the foregoing. The compounds... | 05/05/2011 |
| 20110086862 | POLYMORPHS OF PARDOPRUNOX This invention relates to a process for the preparation of 7-(4-methyl-1-piperazinyl)benzoxazol-2(3H)-one hydrochloride, a partial dopamine-D2 receptor agonist and a full serotonin 5-HT1A receptor agonist. | 04/14/2011 |
| 20110046153 | Medicaments A compound of formal (I) is described: wherein R1 and R2 are as defined in the text and wherein the compounds are intended for use in treating medical conditions characterized by an imbalance in dopamine receptor activity.... | 02/24/2011 |
| 20110003995 | Process for the Preparation of Ziprasidone The present invention relates to a process for preparing Ziprasidone of formula I, or a pharmaceutically acceptable salt or a solvate or a hydrate thereof; | 01/06/2011 |
| 20110003994 | CYCLOALKANE DERIVATIVE The present invention relates to a novel cycloalkane derivative which exhibits an excellent psychotropic action and has less side effect.... | 01/06/2011 |
| 20110003828 | PRODRUGS OF NH-ACIDIC COMPOUNDS The invention provides a method of sustained delivery of a lactam, imide, amide, sulfonamide, carbamate or urea containing parent drug by administering to a patient an effective amount of a prodrug compound of the invention wherein upon administration to the patient, re... | 01/06/2011 |
| 20100329978 | HIGHLY SELECTIVE SIGMA RECEPTOR LIGANDS Compounds having the general formula II, III, or IV wherein R1 can be a radical of an optionally substituted C-4 to C-7 N-containing heterocycle or a radical of an optionally substituted cyclic or ... | 12/30/2010 |
| 20100324015 | HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Disclosed are compounds, compositions and methods for treating diseases, syndromes, conditions and disorders that are affected by the inhibition of MGL, including pain. Such compounds are represented by Formula (I) as follows:
|
